Skip to main content

Advertisement

ADVERTISEMENT

Podcasts

Manju T Beier PharmD BCGP FASCP
Podcast Series
03/08/2022
Edan Stanley
Manju T Beier, Pharm D, BCGP, FASCP, senior partner, Geriatric Consultant Resources LLC, and adjunct associate professor of pharmacy, The University of Michigan, Ann Arbor, MI, discusses the overall prevalence and risks associated with...
Manju T Beier, Pharm D, BCGP, FASCP, senior partner, Geriatric Consultant Resources LLC, and adjunct associate professor of pharmacy, The University of Michigan, Ann Arbor, MI, discusses the overall prevalence and risks associated with...
Manju T Beier, Pharm D, BCGP,...
03/08/2022
Annals of Long-Term Care

Advertisement

Headshot of Vivian Shi, UAMS, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
02/24/2022
Maria Asimopoulos
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, highlights clinical scenarios in which a topical treatment for atopic dermatitis may be most effective.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, highlights clinical scenarios in which a topical treatment for atopic dermatitis may be most effective.
Vivian Shi, MD, FAAD, associate...
02/24/2022
First Report Managed Care
Headshot of Gary Owens, Gary Owens Associates, on a blue background underneath PopHealth Perspectives logo
Podcasts
02/16/2022
Samantha Matthews
Gary Owens, MD, president of Gary Owens Associates, reviews what payers should know about cabotegravir as it hits the market, as well as how future treatment options could impact costs and patient care.
Gary Owens, MD, president of Gary Owens Associates, reviews what payers should know about cabotegravir as it hits the market, as well as how future treatment options could impact costs and patient care.
Gary Owens, MD, president of...
02/16/2022
First Report Managed Care
Headshot of Vivian Shi, UAMS, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
02/15/2022
Maria Asimopoulos
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, provides an overview of a recently approved treatment for atopic dermatitis.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, provides an overview of a recently approved treatment for atopic dermatitis.
Vivian Shi, MD, FAAD, associate...
02/15/2022
First Report Managed Care

Advertisement

Headshot of Gary Owens, Gary Owens Associates, on a blue background underneath PopHealth Perspectives logo
Podcasts
02/07/2022
Samantha Matthews
Gary Owens, MD, president of Gary Owens Associates, discusses the financial burdens of HIV and the challenges payers face when covering this patient population.
Gary Owens, MD, president of Gary Owens Associates, discusses the financial burdens of HIV and the challenges payers face when covering this patient population.
Gary Owens, MD, president of...
02/07/2022
First Report Managed Care
Headshot of Vivian Shi, UAMS, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
02/01/2022
Maria Asimopoulos
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, reviews the symptoms of atopic dermatitis, the prevalence of the condition in her clinical practice, and the unmet needs of this patient...
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, reviews the symptoms of atopic dermatitis, the prevalence of the condition in her clinical practice, and the unmet needs of this patient...
Vivian Shi, MD, FAAD, associate...
02/01/2022
First Report Managed Care
Headshot of Shebli Atrash, Levine Cancer Institute, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/29/2021
Maria Asimopoulos
Samantha Matthews
Shebli Atrash, MD, physician, plasma cell disorder team, Levine Cancer Institute, North Carolina, highlights findings presented at the 63rd ASH Annual Meeting & Exposition that indicated racial discrepancies in patients’ access to timely...
Shebli Atrash, MD, physician, plasma cell disorder team, Levine Cancer Institute, North Carolina, highlights findings presented at the 63rd ASH Annual Meeting & Exposition that indicated racial discrepancies in patients’ access to timely...
Shebli Atrash, MD, physician,...
12/29/2021
First Report Managed Care

Advertisement

Headshot of Daniel Lee, UCSD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/29/2021
Maria Asimopoulos
In part two of this podcast series, Daniel Lee, MD, clinical director, Pacific AIDS Education Training Center HIV Learning Network, and director, Owen Lipid/Lipodystrophy Clinic, University of California–San Diego, discusses the therapies...
In part two of this podcast series, Daniel Lee, MD, clinical director, Pacific AIDS Education Training Center HIV Learning Network, and director, Owen Lipid/Lipodystrophy Clinic, University of California–San Diego, discusses the therapies...
In part two of this podcast...
12/29/2021
First Report Managed Care
Headshot of Daniel Lee, UCSD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/21/2021
Maria Asimopoulos
In part one of this podcast series, Daniel Lee, MD, clinical director, Pacific AIDS Education Training Center HIV Learning Network, and director, Owen Lipid/Lipodystrophy Clinic, University of California–San Diego, offers insight into the...
In part one of this podcast series, Daniel Lee, MD, clinical director, Pacific AIDS Education Training Center HIV Learning Network, and director, Owen Lipid/Lipodystrophy Clinic, University of California–San Diego, offers insight into the...
In part one of this podcast...
12/21/2021
First Report Managed Care
Headshot of Adam Kittai, Ohio State University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/14/2021
Maria Asimopoulos
In part two of this podcast series, Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, highlights findings from the CAPTIVATE study regarding the efficacy of ibrutinib vs placebo for disease-free...
In part two of this podcast series, Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, highlights findings from the CAPTIVATE study regarding the efficacy of ibrutinib vs placebo for disease-free...
In part two of this podcast...
12/14/2021
First Report Managed Care

Advertisement

Advertisement